183 related articles for article (PubMed ID: 18420432)
21. Novel human pathological mutations. Gene symbol: SLC40A1. Disease: haemochromatosis, type 4.
Relvas L; Claro MT; Bento MC; Ribeiro ML
Hum Genet; 2009 Apr; 125(3):338. PubMed ID: 19309784
[No Abstract] [Full Text] [Related]
22. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease.
Pietrangelo A; Corradini E; Ferrara F; Vegetti A; De Jong G; Luca Abbati G; Paolo Arcuri P; Martinelli S; Cerofolini E
Blood Cells Mol Dis; 2006; 37(3):192-6. PubMed ID: 17052926
[TBL] [Abstract][Full Text] [Related]
24. SLC40A1-R178G mutation and ferroportin disease.
Speletas M; Onoufriadis E; Kioumi A; Germenis AE
J Hepatol; 2011 Sep; 55(3):730-731. PubMed ID: 21320560
[No Abstract] [Full Text] [Related]
25. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.
Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE
Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113
[TBL] [Abstract][Full Text] [Related]
26. [Fundamentals of the laboratory diagnosis in inherited hemochromatosis (literature survey)].
Kazanets EG; Karamian NA
Klin Lab Diagn; 2004 Oct; (10):7-13. PubMed ID: 15584392
[No Abstract] [Full Text] [Related]
27. HJV hemochromatosis, iron overload, and hypogonadism in a Brazilian man: treatment with phlebotomy and deferasirox.
Santos PC; Cançado RD; Pereira AC; Chiattone CS; Krieger JE; Guerra-Shinohara EM
Acta Haematol; 2010; 124(4):204-5. PubMed ID: 21071928
[No Abstract] [Full Text] [Related]
28. SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting.
Wallace DF
J Hepatol; 2013 Aug; 59(2):396-7. PubMed ID: 23523714
[No Abstract] [Full Text] [Related]
29. Reply to: "SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting".
Speletas M; Kioumi A; Germenis AE
J Hepatol; 2013 Aug; 59(2):397. PubMed ID: 23523713
[No Abstract] [Full Text] [Related]
30. [Usefulness of a diagnostic algorithm hyperferritinemia: A case report of a Spanish family with hereditary hemochromatosis and mutation in SLC40A1 gene].
Vargas JA; Muñoz A; Samper B; Bornstein B
Med Clin (Barc); 2015 Jul; 145(1):42-3. PubMed ID: 25441019
[No Abstract] [Full Text] [Related]
31. [Iron metabolism and its exploration in clinical biology].
Brissot P; Pigeon C; Moirand R; Guyader D; Mendler MH; Sapey T; Deugnier Y; Lescoat G; Loréal O
Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():5-10. PubMed ID: 9827209
[No Abstract] [Full Text] [Related]
32. The ferroportin disease.
Pietrangelo A
Blood Cells Mol Dis; 2004; 32(1):131-8. PubMed ID: 14757427
[TBL] [Abstract][Full Text] [Related]
33. Gene symbol: SLC40A1. Disease: Primary iron overload.
Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
Hum Genet; 2005 May; 116(6):541. PubMed ID: 15991323
[No Abstract] [Full Text] [Related]
34. The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis.
Rovati A; Bergamaschi G; Casula S; Cerani P; Grasso M; Cazzola M
Haematologica; 1999 Feb; 84(2):182-3. PubMed ID: 10091420
[No Abstract] [Full Text] [Related]
35. Gene symbol: SLC40A1. Disease: primary iron overload.
Zaahl MG; Merryweather-Clarke AT; Kotze MJ; van der Merwe S; Warnich L; Robson KJ
Hum Genet; 2005 Dec; 118(3-4):547. PubMed ID: 16521305
[No Abstract] [Full Text] [Related]
36. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O
Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237
[TBL] [Abstract][Full Text] [Related]
37. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis.
Wallace DF; Clark RM; Harley HA; Subramaniam VN
J Hepatol; 2004 Apr; 40(4):710-3. PubMed ID: 15030991
[TBL] [Abstract][Full Text] [Related]
38. Iron overload due to mutations in ferroportin.
De Domenico I; Ward DM; Musci G; Kaplan J
Haematologica; 2006 Jan; 91(1):92-5. PubMed ID: 16434376
[TBL] [Abstract][Full Text] [Related]
39. A 49-year-old man with alpha 1-antitrypsin deficiency and abnormal iron study results.
Brunt EM; Tavill AS; Bacon BR
Semin Liver Dis; 1996 Feb; 16(1):97-101. PubMed ID: 8723327
[No Abstract] [Full Text] [Related]
40. Ferroportin disease: A novel SLC40A1 mutation.
Ravasi G; Pelucchi S; Russo A; Mariani R; Piperno A
Dig Liver Dis; 2020 Jun; 52(6):688-690. PubMed ID: 32360131
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
